Completeness compared with WHO recommendations
| WHO/IARC Variable . | Present in TASH Registry . | Present in Jimma Registry . |
|---|---|---|
| The person | ||
| Personal identification | Yes | Yes |
| Date of birth | No | No |
| Sex | Yes | Yes |
| Ethnic group | Yes | Yes |
| Address (postal/ZIP code and phone number) | Yes | Yes |
| The tumor | ||
| Incidence date | Yes | Yes |
| Primary tumor site | Yes | Yes |
| Laterality | No | No |
| Primary tumor histology | No | Yes |
| Behavior | No | No |
| Basis of diagnosis | No | No |
| Stage (condensed TNM) | Yes | Yes |
| Initial therapy | Yes | Yes |
| Surgery | Yes | Yes |
| Radiotherapy | Yes | Yes |
| Chemotherapy | Yes | Yes |
| Endocrine (hormones) | No | No |
| Sources of information | Yes (diagnostics means) | No |
| Follow-up | ||
| Last follow-up date | No | Yes |
| Vital status (at last follow-up date) | No | No |
| Date of death | Yes | Yes |
| WHO/IARC Variable . | Present in TASH Registry . | Present in Jimma Registry . |
|---|---|---|
| The person | ||
| Personal identification | Yes | Yes |
| Date of birth | No | No |
| Sex | Yes | Yes |
| Ethnic group | Yes | Yes |
| Address (postal/ZIP code and phone number) | Yes | Yes |
| The tumor | ||
| Incidence date | Yes | Yes |
| Primary tumor site | Yes | Yes |
| Laterality | No | No |
| Primary tumor histology | No | Yes |
| Behavior | No | No |
| Basis of diagnosis | No | No |
| Stage (condensed TNM) | Yes | Yes |
| Initial therapy | Yes | Yes |
| Surgery | Yes | Yes |
| Radiotherapy | Yes | Yes |
| Chemotherapy | Yes | Yes |
| Endocrine (hormones) | No | No |
| Sources of information | Yes (diagnostics means) | No |
| Follow-up | ||
| Last follow-up date | No | Yes |
| Vital status (at last follow-up date) | No | No |
| Date of death | Yes | Yes |
We noted many differences between the data sheets for the 2 hospitals and with WHO/International Agency for Research on Cancer (IARC) recommended variables. We estimated the overall rate of completion to be <50%.
ZIP, Zone Improvement Plan.